The CDC’s Elimination of Perinatal HIV Transmission Case Finding and Community Action Stakeholders Group
in collaboration with the
FIMR/HIV Prevention Methodology National Resource Center at CityMatCH
presents:
“Trauma-Informed Care: An Approach to Improve Engagement of Women Living with HIV”
Thursday, November 12th, 2015
Noon-1:30 pm ET/ 11- MORE

(July 23, 2015) The U.S. Food and Drug Administration approved the Bio-Rad BioPlex 2200 HIV Ag-Ab assay, the first FDA-approved diagnostic that differentiates between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen in human serum or plasma specimens.
Two major types of HIV have been identified: HIV-1 and HIV-2. HIV-1 is responsible for most HIV MORE

Greetings!
Registration is open for our 2015-16 Open Enrollment program schedule. As a federally-funded center, MATEC offers targeted HIV training to healthcare professionals and other providers. To register for a training session, find the program on the left column and click on the date.
Please note that MATEC will be moving our office and MORE

Please remind your clients -- consumers receiving Advanced Premium Tax Credits (APTCs) should file their 2014 taxes, including Form 8962, before August 31 or ASAP so they can continue receiving APTCs next year. While the Internal Revenue Service deadline is October 15, filing taxes before August 31 will best ensure consumers avoid any gaps in their MORE

Today, MATEC launches our new website with a new look and feel. We'll be keeping you current with the latest news and resources on HIV treatment therapies and guidelines. You can continue to register for MATEC programs and learn about our latest projects throughout the region and in each state.
If you are looking for upcoming programs, click on your MORE

Mr. Gordon Dawson-Tibbits has joined the staff at MATEC's Central Office as the new Business Operations Assistant. In this capacity, Gordon will be assisting in our Business Office with the financial workflow of the Center, and will be ensuring that our office space, and all the resources we have available for our staff, are in working order. He will also MORE

On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults.
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Flu infections can range from mild to severe and can sometimes lead to hospitalization and death. According to the Centers for MORE

The Affordable Care Act made some major changes in the way individuals and families can access health insurance. This bi-weekly update throughout open enrollment is designed to provide information about health care changes for providers. While this is meant to highlight some important changes and updates, it is not an exhaustive list.
1. December 15th MORE

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
Viekira Pak contains three new drugs-ombitasvir, MORE

On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults.
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Flu infections can range from mild to severe and can sometimes lead to hospitalization and death. According to the Centers for MORE